Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More 11/30/12 Boston
Rib-X Closes First Tranche of $67.5 Million Preferred Stock Financing 11/29/12 Boston
Rib-X Pharmaceuticals Lands Series B Financing Round 11/29/12 Boston
Athenahealth, iRobot, PerkinElmer, & More in Boston Life Sciences News 09/14/12 Boston
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers 04/27/12 Boston
Rib-X Pharma Files for IPO 11/28/11 Boston
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News 07/08/11 Boston
Rib-X Inks Research Agreement With Sanofi 07/06/11 Boston
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made 04/04/11 National
Rib-X Pharmaceuticals Garners $5,500,000 New Round 01/28/11 Boston
Rib-X Wrappes Up $20M, Oxford Closes $66M on Sixth Fund, Ocular Adds $6M, & More Boston-Area Life Sciences News 01/14/11 Boston
$12.7M Blows in for Wind Power Holdings, Epizyme Forges Alliance with GlaxoSmithKline, & Many More Boston-Area Deals 01/12/11 Boston
Rib-X Raises Another $20M, Led by Warburg Pincus, to Develop Late Stage Antibiotics 01/11/11 Boston
Rib-X Pharmaceuticals Receives $20,000,000 New Financing Round 01/11/11 Boston
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference 09/15/10 Boston
Mercator Therapeutics Embarks on Journey to Develop Targeted Cancer Drugs 09/01/10 Boston
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News 06/16/10 Boston
Rib-X Adds $5.5M Debt 06/11/10 Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics 06/01/10 Boston
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News 03/26/10 Boston
Former Targanta CEO Leuchtenberger Lands New Gig at Rib-X, Another Antibiotic Company 03/23/10 Boston
Sirtris Founders Resurface with New Fund, Icahn Continues to Make Biotech Waves, Sentillion Bought by Microsoft, & More Boston-Area Life Sciences News 02/19/10 Boston
Rib-X Maps Out Pivotal Antibiotic Trial, As Part of Built-to-Last Company Strategy 02/16/10 Boston
Rib-X Founder Gets Nobel Prize 10/07/09 Boston
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News 08/12/09 Boston
Rib-X Antibiotic Passes Clinical Trial, Hopes to Snag Partner 08/05/09 Boston
Exact Teams With Genzyme, Shrugs off Sequenom; Virtual Computer Reels in $15M; Beacon Power Inks National Grid Agreement; & More Boston-Area Deal News 01/30/09 Boston
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News 01/28/09 Boston
Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial 01/26/09 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.